BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 26, 2026
Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

SEMDA 2015: TriNet's Goldfield looking for vision, technology when making acquisitions

April 2, 2015
By Omar Ford

SEMDA 2015: Data, regulatory hurdles dominate first day of SEMDA conference

April 1, 2015
By Omar Ford

AAOS 2015: Syncera changes paradigm of orthopedic sales model

March 31, 2015
By Omar Ford

LAS VEGAS — Just across from Smith & Nephew's (S&N; London) 90X100 makeshift office on the exhibit floor at the American Academy of Orthopedic Surgeons (Rosemont, Illinois) annual meeting – lies Syncera (Mansfield, Massachusetts), a business unit set to change the model of how orthopedic products are sold.


Read More

AAOS 2015: Cayenne Medical releases 2-year results of Mirror Partial Knee study

March 30, 2015
By Omar Ford

AAOS 2015 conference: Value over volume is the new shift in treating patients

March 30, 2015
By Omar Ford

LAS VEGAS — Reimbursement. Physician pay. Value over volume. All are words that were pretty common at the American Association of Orthopedic Surgeons (AAOS; Rosemont Illinois), annual meeting held last week at the Venetian/Sands EXPO in Las Vegas.


Read More

MDD's Diagnostics Extra

March 27, 2015
By Omar Ford

AAOS 2015: Bioventus establishes its identity, products in ortho-biologics space

March 27, 2015
By Omar Ford

LAS VEGAS — Three years ago, Smith & Nephew (S&N; London) spun off its biologics unit in partnership with Woodlands Essex to form Bioventus (Durham, North Carolina). Fast forward to today, and Bioventus is maintaining a global presence in the biologics market, with about 500 employees strong, and nearly $240 million dollars in yearly revenue.


Read More

AAOS 2015 Meeting: Depuy reaffirms R&D commitment, introduces new products at AAOS

March 26, 2015
By Omar Ford

LAS VEGAS — Nearly four years ago, Johnson & Johnson (J&J;New Brunswick, New Jersey) revealed its intent to acquire Synthes (Solothurn, Switzerland), a firm that develops surgical devices used to treat fractures and traumatic injuries for $21.3 billion. Synthes, has now been carefully folded into J&J's Depuy (Warsaw, Indiana).


Read More

AAOS 2015 Annual Meeting: AAOS panel talks bridging the gap in technological advances in healthcare

March 25, 2015
By Omar Ford

Teleflex hoping Percuvance paves way for category of percutaneous surgery

March 24, 2015
By Omar Ford
View All Articles by Omar Ford

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • 3D rendering of skin cells and elastin with collagen layer

    First-in-class pan-inflammasome blocker for hidradenitis suppurativa

    BioWorld Science
    Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld
    Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing